CauchyMed is focused on providing full-Service CRO for orphan drugs and advanced therapy. We provide our clients comprehensive services in Project Management (Phase I-IV), Clinical Monitoring, Regulatory Affairs, Statistical Analysis, Data Management, Medical Affairs, and Commercialization Consulting. We have the experience and knowledge to provide the most comprehensive operational and logistical tools, technically advanced services, and forward-thinking solutions to take our clients through the entire process from the initial product concept to NMPA approval, and commercialization. CauchyMed’s leadership team has rich experience in developing medicinal products. Our experts have over 15 years of experience and expertise in conducting the phase I-IV studies of orphan drugs and advanced therapy, developing orphan medicines and advanced therapy from NMPA submission & approval to commercialization. We have experience in the following therapeutic areas for rare diseases, Advanced Therapy, and RWE: Orphan Indication Hematology Oncology Endocrinology Respiratory Orthopedics Cardiovascular Gastroenterology Central Nervous System (CNS) Nephrology Ophthalmology Radiology Dermatology HIV Medical Devices Vaccines